Internal Medicine, Transplant Hepatology · Cherry Hill, NJ
NPI
1073573663
Since 2006
Specialty
Internal Medicine, Transplant Hepatology
Code 207RT0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
63 Kresson Rd Ste 101c
Cherry Hill, NJ, 08034
Phone (856) 796-9340
Groups this clinician bills Medicare through
Medicare paid, 2024
$47K
681 services
Medicare patients, 2024
390
Average age 69
Drug cost, 2024
$1.0M
1,510 prescriptions
Company payments, 2025
$88K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hisham Elgenaidi was code 91200 (standard x-ray), 201 times for 194 patients. In total Hisham Elgenaidi billed 681 services in 15 codes, and Medicare paid $47K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 91200 Standard X-ray | Facility | 201 | 194 | $8.62 | $1,732 |
| 99214 Office E&M - Established | Office | 129 | 87 | $107.07 | $14K |
| 99213 Office E&M - Established | Office | 127 | 91 | $76.00 | $9,652 |
| 99232 Hospital E&M - Subsequent | Facility | 93 | 45 | $68.49 | $6,370 |
| 99222 Hospital E&M - Initial | Facility | 44 | 43 | $114.77 | $5,050 |
| 99203 Office E&M - New | Office | 26 | 26 | $98.07 | $2,550 |
| 99204 Office E&M - New | Office | 25 | 25 | $139.46 | $3,486 |
| 99233 Hospital E&M - Subsequent | Facility | 20 | 11 | $104.86 | $2,097 |
By year: 2022 $43K for 555 services; 2023 $47K for 691 services; 2024 $47K for 681 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hisham Elgenaidi prescribed most often to Medicare patients was Ursodiol, with 169 prescriptions and refills. In total Hisham Elgenaidi wrote 1,510 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ursodiol Generic | 169 | 244 | 38 | $16K |
| Tacrolimus Generic | 154 | 288 | 31 | $20K |
| Spironolactone Generic | 94 | 154 | 22 | $1,526 |
| Furosemide Generic | 91 | 151 | 24 | $323 |
| Entecavir Generic | 67 | 87 | 11 | $12K |
| Xifaxan Rifaximin | 62 | 64 | 15 | $213K |
| Lactulose Generic | 62 | 112 | 24 | $3,630 |
| Rezdiffra Resmetirom | 59 | 61 | 12 | $240K |
| Pantoprazole Sodium Generic | 54 | 76 | Under 11 | $390 |
| Azathioprine Generic | 53 | 90 | Under 11 | $2,487 |
| Metoprolol Tartrate Generic | 44 | 84 | Under 11 | $188 |
| Mycophenolic Acid Mycophenolate Sodium | 42 | 52 | Under 11 | $6,151 |
| Prednisone Generic | 36 | 65 | Under 11 | $190 |
| Amlodipine Besylate Generic | 34 | 60 | Under 11 | $108 |
| Carvedilol Generic | 33 | 89 | Under 11 | $232 |
Brand drugs: 222 claims; generic drugs: 1,288 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hisham Elgenaidi $88K ($88K in general payments such as food, travel and fees) from 11 companies. The largest payer was Ipsen Biopharmaceuticals, Inc with $27K.
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc IPN.PA | 25 | $27K |
| Madrigal Pharmaceuticals MDGL | 31 | $25K |
| Gilead Sciences, Inc. GILD | 39 | $14K |
| Novo Nordisk Inc NVO | 12 | $12K |
| Abbvie Inc. ABBV | 18 | $8,754 |
| Mallinckrodt Hospital Products Inc. | 1 | $1,200 |
| Mirum Pharmaceuticals, Inc. MIRM | 2 | $145 |
| Histosonics, Inc. | 1 | $84.13 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $36.21 |
| Orphalan Inc | 1 | $19.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.